PDS Biotechnology Corporation
PDSB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $47 | $61 | $48 | $59 |
| - Cash | $26,199 | $32 | $40 | $42 |
| + Debt | $78 | $19 | $19 | $22 |
| Enterprise Value | -$26,074 | $48 | $27 | $40 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$8 | -$7 | -$9 | -$7 |
| % Margin | – | – | – | – |
| Net Income | -$9 | -$9 | -$8 | -$8 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.19 | -0.21 | -0.21 | -0.22 |
| % Growth | 9.5% | 0% | 4.5% | – |
| Operating Cash Flow | -$6 | -$9 | -$9 | -$8 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6 | -$9 | -$9 | -$8 |